On August 13, 2024, Brian Dorsey, Chief Operating Officer of ARS Pharmaceuticals Inc (NASDAQ:SPRY), sold 30,000 shares of the company’s stock. The transaction was documented in a recent SEC filing. Following this sale, the insider now owns 6,024 shares of the company’s stock. ARS Pharmaceuticals Inc (NASDAQ:SPRY) is focused on developing novel medicines to improve […]